Continuous ambulatory vestibular assessment (CAVA) - development of a system to provide an automatic diagnosis for vestibular conditions

orfolk and Norwich University Hospitals NHS Foundation Trust0 个研究点目标入组 255 人开始时间: 2023年1月31日最近更新: 2023年3月6日

试验速览

暂无简介。

•1. Age 18 years and over
•2. Must have relevant index medical condition: Ménière’s disease, vestibular migraine, posterior canal benign paroxysmal positional vertigo
•3. Experiencing episodes of true vertigo with at least two episodes within the preceding 4 weeks at time of consent
•4. The duration and nature of the vertigo is of a duration and a nature supportive of the relevant index medical condition
•5. Owns and is able to use a telephone
•6. Willing to provide informed consent
•7. Willing to comply with the study protocol for using the CAVA device
•8. Willing to complete all study materials
•9. Adequate grasp of the English language or language used within an existing translated version of the informed consent form and patient information sheet and where hospital translators are available to provide support

•1. Has an allergy to plasters and/or medical adhesives
•2. Evidence of dermatitis, fragile skin, or any other condition that could be aggravated by the repeated application of skin surface adhesives
•3. Pregnant or breastfeeding mothers
•4. Bilateral or second side Ménière’s disease
•5. Active bilateral or second side posterior canal benign paroxysmal positional vertigo
•6. Currently enrolled on an intervention trial (not including questionnaire-based or observational trial)
•7. Patients who meet diagnostic criteria for more than one eligible condition at time of recruitment

发起方